Latest Breaking News On - Xiaolin liu - Page 1 : comparemela.com

Bitterroot Bio and Biotheus Announce Research Collaboration

Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease.

Jun baoPavan cheruvuXiaolin liuBitterroot bio

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology

Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jun baoXiaolin liuPavan cheruvuBitterroot bio

BioNTech acquires right to Biotheus bispecific antibody candidate in deal worth over $1bn

BioNTech acquires right to Biotheus bispecific antibody candidate in deal worth over $1bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Xiaolin liuDuality biologics

BioNTech licenses bispecific antibody for cancer in $1 billion deal

The German mRNA giant BioNTech has sealed a pact worth up to $1 billion with Biotheus to develop the Chinese biotech company’s bispecific antibody cancer drug PM8002 in all territories except for Greater China.

Xiaolin liuAntibody drug conjugatesBio developmentsBispecific antibodiesMonoclonal antibodiesCell culture

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications

Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Fosun pharmaJun baoXiaolin liuRoche groupPrnewswire biotheus incGoby globalBiotheus incBispecific antibody candidateGreater chinaAntitrust improvements actNew technologiesDuality biologics